[Inflammatory cardiomyopathy: state-of-the-art].
Cardiomyopathy (CMP) is a major cause of early disability and death in young cardiac patients, remaining at the same time a little studied problem. The generally accepted term "dilated cardiomyopathy" is only a portrayal of morphological signs. As of now, the foreign literature most commonly uses the term "inflammatory cardiomyopathy" to denote CMP caused by viral and/or bacterial agents. Owing to the wide use of novel laboratory and instrumental diagnostic techniques, namely: molecular genetic and immunohistochemical studies and endomyocardial biopsy, there has been a possibility to conduct a more accurate and fuller study of inflammatory CMP. Despite the fact that the problems in nosology, classification, choice of the optimal diagnostic methods and management tactics for these patients.
Beliavskiĭ
E A
EA
Zykov
K A
KA
Narusov
O Iu
OIu
Masenko
V P
VP
Skvortsov
A A
AA
Shchedrina
A Iu
AIu
Tereshchenko
S N
SN
D002311:Cardiomyopathy, Dilated / Q000145:classification / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology; D002986:Clinical Trials as Topic; D006321:Heart / Q000382:microbiology / Q000821:virology; D006801:Humans; D009205:Myocarditis / Q000145:classification / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology; D016896:Treatment Outcome